All News #Library
Rare Diseases
Biocryst Launches ORLADEYO Oral Pellets For Pediatric HAE
12 Dec 2025 //
GLOBENEWSWIRE
Biocryst Reveals Orladeyo`s Sustained Efficacy In Pediatric HAE
06 Nov 2025 //
GLOBENEWSWIRE
Biocryst Expands Rare Diseases Focus In $700M Astria Deal
14 Oct 2025 //
FIERCE BIOTECH
BioCryst names Babar Ghias CFO, Head of Corporate Development
07 Jul 2025 //
GLOBENEWSWIRE
BioCryst to Present at Upcoming Investor Conference
02 Apr 2025 //
GLOBENEWSWIRE
BioCryst stockholders call off merger with Idera Pharmaceuticals
11 Jul 2018 //
FIERCE BIOTECH

Market Place
Sourcing Support